![Sheldon Koenig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheldon Koenig
Vorstandsvorsitzender bei
ESPERION THERAPEUTICS, INC.
Vermögen: 7 Mio $ am 31.05.2026
Profil
Sheldon L.
Koenig is the founder of Nuvig Therapeutics, Inc. Currently, Mr. Koenig is President, Chief Executive Officer & Director at Esperion Therapeutics, Inc. since 2021.
Formerly, Mr. Koenig was Vice President at Merck & Co., Inc. from 2009 to 2015, Chief Commercial Officer & Executive VP at Portola Pharmaceuticals LLC from 2019 to 2020, and Senior VP & Head-Cardiovascular Franchise at Sanofi Corp.
Education includes an undergraduate degree from Drexel University and an MBA from Monmouth University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 2’119’111 ( 0.82% ) | 7 Mio $ | 31.05.2026 |
Aktive Positionen von Sheldon Koenig
| Unternehmen | Position | Beginn |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Vorstandsvorsitzender | 18.05.2021 |
Ehemalige bekannte Positionen von Sheldon Koenig
| Unternehmen | Position | Ende |
|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2020 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2015 |
Nuvig Therapeutics, Inc.
 Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Gründer | - |
Sanofi Corp.
 Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a healthcare company that aims to improve people's lives through science by discovering, developing, and delivering medicines and vaccines for millions of people around the world. The company is comprised of four business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare. With over 100,000 employees around the globe, Sanofi is dedicated to chasing the miracles of science to improve the lives of millions of patients. The company is based in Bridgewater, NJ. | Corporate Officer/Principal | - |
Ausbildung von Sheldon Koenig
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monmouth University
 Monmouth University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Corp.
Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a healthcare company that aims to improve people's lives through science by discovering, developing, and delivering medicines and vaccines for millions of people around the world. The company is comprised of four business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare. With over 100,000 employees around the globe, Sanofi is dedicated to chasing the miracles of science to improve the lives of millions of patients. The company is based in Bridgewater, NJ. | Health Technology |
Nuvig Therapeutics, Inc.
Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Health Technology |
